SynLeGG: analysis and visualization of multiomics data for discovery of cancer 'Achilles Heels' and gene function

Mark Wappett1,2, Adam Harris1, Alexander L R Lubbock3

  • 1Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.

Insights

SynLeGG identifies genetic dependency relationships (GDRs) by analyzing gene expression data, uncovering Achilles' heel vulnerabilities for precision cancer therapy. This approach enhances the discovery of synthetic lethality across diverse cancer cell lines and tissues.

Area of Science:

  • Genomics
  • Computational Biology
  • Cancer Research

Background:

  • Achilles' heel relationships, where one gene's status sensitizes cells to another's perturbation, offer therapeutic targets in precision oncology.
  • Investigating genetic dependency relationships (GDRs) using transcriptome data is underexplored despite its advantages over genetic approaches.

Purpose of the Study:

  • To introduce SynLeGG, a tool for identifying and visualizing mutually exclusive loss signatures in omics data to discover GDRs.
  • To leverage transcriptome data for uncovering novel GDRs and tissue-specific vulnerabilities.

Main Methods:

  • SynLeGG utilizes the MultiSEp algorithm for unsupervised clustering of cell lines based on gene expression.
  • Analysis involves correlating CRISPR scores and mutational status within identified clusters to propose candidate GDRs.
  • Benchmarking against SynLethDB assessed MultiSEp's performance using Receiver Operator Characteristic curves and coverage.

Main Results:

  • MultiSEp demonstrated superior performance compared to competing methods, achieving significantly higher area under the ROC curve and 2.8- to 8.5-fold greater coverage.
  • SynLeGG successfully identified pan-cancer and tissue-specific GDRs, including the known synthetic lethality of SMARCA2 with SMARCA4.
  • Predictions from SynLeGG were significantly enriched in dependencies validated by recent CRISPR screens.

Conclusions:

  • SynLeGG provides a robust platform for discovering genetic dependency relationships using transcriptome data.
  • The tool aids in prioritizing potential drug targets by integrating multi-omics information and identifying vulnerabilities exploitable in cancer therapy.